Để tạo thuận lợi cho công tác nghiên cứu, điều trị và phòng chống dịch viêm đường hô hấp cấp do COVID-19, Cục Thông tin khoa học và công nghệ quốc gia tập hợp danh sách các công bố quốc tế mới nhất về nội dung này (có file toàn văn tại đường link kèm theo) để các bác sĩ, nhân viên y tế và các nhà nghiên cứu của Việt Nam tiện theo dõi. Danh sách sẽ được cập nhật thường xuyên theo tiến độ xuất bản điện tử.
SCIENCEDIRECT
1. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge
International Immunopharmacology, 12 March 2021, Volume 95 (Cover date: June 2021), Article 107579
Lu-Xiao Hong, Lian Liu, Wei-Hua Yan
https://www.sciencedirect.com/science/article/pii/S1567576921002150/pdfft?md5=2f9584b635a03c2c194ef271423c6689&pid=1-s2.0-S1567576921002150-main.pdf
2. Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients
International Journal of Infectious Diseases, 20 January 2021, Volume 104 (Cover date: March 2021), Pages 661-669
C. Serre-Miranda, C. Nobrega, M. Correia-Neves
https://www.sciencedirect.com/science/article/pii/S1201971221000497/pdfft?md5=a865084efc949318d0f236941646dbec&pid=1-s2.0-S1201971221000497-main.pdf
3. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Cell Reports Medicine, 26 January 2021, Volume 2, Issue 2 (Cover date: 16 February 2021), Article 100204
Alison Tarke, John Sidney, Alessandro Sette
https://www.sciencedirect.com/science/article/pii/S266637912100015X/pdfft?md5=03799133cd62631ae1406ddf9c19f9f0&pid=1-s2.0-S266637912100015X-main.pdf
4. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity
iScience, 9 January 2021, Volume 24, Issue 2 (Cover date: 19 February 2021), Article 102052
Monique Bennett, Sandra Yoder, Isaac Thomsen
https://www.sciencedirect.com/science/article/pii/S2589004221000201/pdfft?md5=c2bffdfaa6b5993e31ea34c0a79f7f01&pid=1-s2.0-S2589004221000201-main.pdf
5. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience
Clinical Biochemistry, 30 January 2021, Volume 90 (Cover date: April 2021), Pages 8-14
Laura De Michieli, Luciano Babuin, Allan S. Jaffe
https://www.sciencedirect.com/science/article/pii/S0009912021000229/pdfft?md5=3735ffb91647e163e3253ee367f90666&pid=1-s2.0-S0009912021000229-main.pdf
6. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications
Journal of Theoretical Biology, 26 January 2021, Volume 515 (Cover date: 21 April 2021), Article 110604
Changchuan Yin
https://www.sciencedirect.com/science/article/pii/S0022519321000266/pdfft?md5=642aef87e0e623e1b7eae6d734f018db&pid=1-s2.0-S0022519321000266-main.pdf
7. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
Heliyon, 11 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06426
Omonike A. Olaleye, Manvir Kaur, Tolulope Adebusuyi
https://www.sciencedirect.com/science/article/pii/S2405844021005314/pdfft?md5=11201d55f15665ef2752bff938e570a9&pid=1-s2.0-S2405844021005314-main.pdf
8. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
Journal of Virological Methods, 13 January 2021, Volume 290 (Cover date: April 2021), Article 114064
Tania Regina Tozetto-Mendoza, Kelly Aparecida Kanunfre, Maria Cassia Mendes-Correa
https://www.sciencedirect.com/science/article/pii/S0166093421000033/pdfft?md5=8fc1ce371fd500594071e8c9eb09d119&pid=1-s2.0-S0166093421000033-main.pdf
9. Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2
Gene Reports, 1 March 2021, Volume 23 (Cover date: June 2021), Article 101064
Zaid Almubaid, Hisham Al-Mubaid
https://www.sciencedirect.com/science/article/pii/S2452014421000492/pdfft?md5=3759c4ca1e4a167122036b309cd8faa1&pid=1-s2.0-S2452014421000492-main.pdf
10. A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein
Virus Research, 19 January 2021,Volume 295 (Cover date: 2 April 2021), Article 198305
Sylvie Roy, Karim Ghani, Manuel Caruso
https://www.sciencedirect.com/science/article/pii/S0168170221000125/pdfft?md5=e43f65a00b328b1d7eb9d7f62b56341b&pid=1-s2.0-S0168170221000125-main.pdf
11. Severe acute respiratory syndrome coronavirus 2 infection in asymptomatic pediatric dental patients
The Journal of the American Dental Association, 19 January 2021, Volume 152, Issue 4 (Cover date: April 2021), Pages 277-283
Flavia Lamberghini, Gabriela Trifan, Fernando D. Testai
https://www.sciencedirect.com/science/article/pii/S0002817721000386/pdfft?md5=e8365345cf468faa807eb89df3e3643a&pid=1-s2.0-S0002817721000386-main.pdf
12. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein
Heliyon, 19 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06564
Shweta Alai, Nidhi Gujar, Sunil Gairola
https://www.sciencedirect.com/science/article/pii/S2405844021006678/pdfft?md5=3f4ea06945af0d333aeca1dddbf52d27&pid=1-s2.0-S2405844021006678-main.pdf
13. The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates
Heliyon, 1 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06167
Gajendra Kumar Azad
https://www.sciencedirect.com/science/article/pii/S2405844021002723/pdfft?md5=dd920526fdae447f27fb01cb9f1940a9&pid=1-s2.0-S2405844021002723-main.pdf
14. In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
Informatics in Medicine Unlocked, 12 January 2021, Volume 23 (Cover date: 2021), Article 100516
Elham Aghaee, Marzieh Ghodrati, Jahan B. Ghasemi
https://www.sciencedirect.com/science/article/pii/S235291482100006X/pdfft?md5=2c1662f4779119aa765e50f85159ac8e&pid=1-s2.0-S235291482100006X-main.pdf
15. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available
Clinica Chimica Acta, 17 March 2021, Volume 518 (Cover date: July 2021), Pages 9-16
Thomas Mueller
https://www.sciencedirect.com/science/article/pii/S0009898121000838/pdfft?md5=862a23c51b22a24b7a1d2d301a2db656&pid=1-s2.0-S0009898121000838-main.pdf
16. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
Molecular Cell, 1 January 2021, Volume 81, Issue 3 (Cover date: 4 February 2021), Pages 584-598.e5
Nicholas C. Huston, Han Wan, Anna Marie Pyle
https://www.sciencedirect.com/science/article/pii/S109727652030962X/pdfft?md5=933d44cf2b0794b10abf129094cfd675&pid=1-s2.0-S109727652030962X-main.pdf
17. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens
International Journal of Infectious Diseases, 25 February 2021, Volume 105 (Cover date: April 2021), Pages 617-620
Vijay Singh, Pallavi Upadhyay, John Granger
https://www.sciencedirect.com/science/article/pii/S1201971221001739/pdfft?md5=7d42730b64c829ed94f8732c5a11b0e8&pid=1-s2.0-S1201971221001739-main.pdf
18. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors
Heliyon, 27 February 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06395
Sayantan Laha, Chinmay Saha, Nitai P. Bhattacharyya
https://www.sciencedirect.com/science/article/pii/S2405844021005004/pdfft?md5=c52f4cf4f4a1e4aeafcb28a904e48fe8&pid=1-s2.0-S2405844021005004-main.pdf
19. COVID-19 patients may become predisposed to pulmonary arterial hypertension
Medical Hypotheses, 6 January 2021, Volume 147 (Cover date: February 2021), Article 110483
Yuichiro J. Suzuki, Sofia I. Nikolaienko, Sergiy G. Gychka
https://www.sciencedirect.com/science/article/pii/S0306987721000013/pdfft?md5=f446726b55e9aeddf5e09c61b55b5fac&pid=1-s2.0-S0306987721000013-main.pdf
20. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
Chemical Engineering Journal, 19 March 2021, Volume 418 (Cover date: 15 August 2021), Article 129392
Bin Zheng, Wenchang Peng, Dong Ming
https://www.sciencedirect.com/science/article/pii/S1385894721009803/pdfft?md5=6d94a753430840753ea4f421da2f9a8c&pid=1-s2.0-S1385894721009803-main.pdf
21. Exploring existing drugs: proposing potential compounds in the treatment of COVID-19
Heliyon, 25 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06284
Eva Rahman Kabir, Nashrah Mustafa, Easin Uddin Syed
https://www.sciencedirect.com/science/article/pii/S2405844021003893/pdfft?md5=b16aefbc13f52d9873b314d8609caa08&pid=1-s2.0-S2405844021003893-main.pdf
22. SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection
Biochemistry and Biophysics Reports, 3 February 2021, Volume 26 (Cover date: July 2021), Article 100938
Iman Hassan Ibrahim, Doha El-Sayed Ellakwa
https://www.sciencedirect.com/science/article/pii/S2405580821000327/pdfft?md5=146c1d31b18d5ad03cff118b6cedb51d&pid=1-s2.0-S2405580821000327-main.pdf
23. Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties
Heliyon, 26 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06603
Ayoub Khaldan, Soukaina Bouamrane, Tahar Lakhlifi
https://www.sciencedirect.com/science/article/pii/S2405844021007064/pdfft?md5=6c65d33372ba36dbc9751ee7268bfa2c&pid=1-s2.0-S2405844021007064-main.pdf
24. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
International Journal of Infectious Diseases, 12 February 2021, Volume 105 (Cover date: April 2021), Pages 21-25
Gustavo Echeverría, Ángel Guevara, Jacobus H. de Waard
https://www.sciencedirect.com/science/article/pii/S120197122100120X/pdfft?md5=2c977222acaa76322d495e77026701c9&pid=1-s2.0-S120197122100120X-main.pdf
25. Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach
Inorganica Chimica Acta, 11 February 2021, Volume 519 (Cover date: 1 May 2021), Article 120287
Thomas Scior, Hassan H. Abdallah, Dieter Rehder
https://www.sciencedirect.com/science/article/pii/S0020169321000438/pdfft?md5=17cd09fb035aea07bac8451b73511c16&pid=1-s2.0-S0020169321000438-main.pdf
26. Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2
Journal of King Saud University - Science, 4 February 2021, Volume 33, Issue 2 (Cover date: March 2021), Article 101352
Mebarka Ouassaf, Salah Belaidi, Thet Thet Htar
https://www.sciencedirect.com/science/article/pii/S1018364721000136/pdfft?md5=ec6f02d5f0a65701962caacf1d380457&pid=1-s2.0-S1018364721000136-main.pdf
27. Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection
Biosensors and Bioelectronics, 16 March 2021, Volume 183 (Cover date: 1 July 2021), Article 113165
Richard B. M. Schasfoort, Jos van Weperen, A. H. Leontine Mulder
https://www.sciencedirect.com/science/article/pii/S0956566321002025/pdfft?md5=3d8cb25fb1b78a15a5b195e0a894b6d3&pid=1-s2.0-S0956566321002025-main.pdf
28. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
Journal of Infection, 13 February 2021, Volume 82, Issue 3 (Cover date: March 2021), Pages 399-406
Letícia Adrielle dos Santos, Pedro Germano de Góis Filho, Roque Pacheco de Almeida
https://www.sciencedirect.com/science/article/pii/S0163445321000438/pdfft?md5=3f70e463ae0a6dafe7718f1925e218f9&pid=1-s2.0-S0163445321000438-main.pdf
29. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19
Phytomedicine Plus, 18 March 2021, Volume 1, Issue 4 (Cover date: November 2021), Article 100058
Jin A. Shin, Subin Oh, Jong-Moon Jeong
https://www.sciencedirect.com/science/article/pii/S2667031321000403/pdfft?md5=bd8fa1fe021061f6ae650dba37d6ed7c&pid=1-s2.0-S2667031321000403-main.pdf
30. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus
Carbohydrate Polymers, 14 February 2021, Volume 260 (Cover date: 15 May 2021), Article 117797
Lufeng Yan, Yuefan Song, Robert J. Linhardt
https://www.sciencedirect.com/science/article/pii/S0144861721001843/pdfft?md5=647638eea2da96df6e1355d07fb69bc4&pid=1-s2.0-S0144861721001843-main.pdf
31. Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays
EBioMedicine, 12 February 2021, Volume 64 (Cover date: February 2021), Article 103236
Nuttada Panpradist, Qin Wang, Barry R. Lutz
https://www.sciencedirect.com/science/article/pii/S2352396421000293/pdfft?md5=c38908e9eb5729ed897439a9d7d4ba20&pid=1-s2.0-S2352396421000293-main.pdf
32. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019
Heliyon, 8 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e05990
M. F. Nagoor Meeran, Hayate Javed, Shreesh Ojha
https://www.sciencedirect.com/science/article/pii/S2405844021000955/pdfft?md5=1fe35b959982569aebfc1c515521d1de&pid=1-s2.0-S2405844021000955-main.pdf
33. SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
Diagnostic Microbiology and Infectious Disease, 9 February 2021, Volume 100, Issue 2 (Cover date: June 2021), Article 115338
Saurabh Gombar, Timothy Bergquist, Niaz Banaei
https://www.sciencedirect.com/science/article/pii/S0732889321000316/pdfft?md5=dce5178a3c7efff254f746718e796f8c&pid=1-s2.0-S0732889321000316-main.pdf
34. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
Atherosclerosis, 15 February 2021, Volume 322 (Cover date: April 2021), Pages 39-50
Thiago Quinaglia, Mahsima Shabani, Andrei C. Sposito
https://www.sciencedirect.com/science/article/pii/S002191502100068X/pdfft?md5=8ccf2b82875e6ea0429a01f1b8395bfe&pid=1-s2.0-S002191502100068X-main.pdf
35. In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach
European Journal of Pharmaceutical Sciences, 19 February 2021, Volume 160 (Cover date: 1 May 2021), Article 105771
Yiming Zhang, Rory A Greer,Yuhua Song
https://www.sciencedirect.com/science/article/pii/S0928098721000737/pdfft?md5=6e40812d782c9dff061d7752eea5f8a0&pid=1-s2.0-S0928098721000737-main.pdf
36. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Cell, 9 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1858-1864.e10
Elizabeth M. Anderson, Eileen C. Goodwin, Scott E. Hensley
https://www.sciencedirect.com/science/article/pii/S0092867421001604/pdfft?md5=88f3d2ad80e0da8270e1fadc3b429e74&pid=1-s2.0-S0092867421001604-main.pdf
37. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro
Biochemical and Biophysical Research Communications, 10 February 2021, Volume 547 (Cover date: 2 April 2021), Pages 23-28
Minsu Jang, Rackhyun Park, Junsoo Park
https://www.sciencedirect.com/science/article/pii/S0006291X21001935/pdfft?md5=0b62e3049eedeaf8e7aabde38bbb8c0c&pid=1-s2.0-S0006291X21001935-main.pdf
38. Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019
Cytokine, 19 March 2021, Volume 142 (Cover date: June 2021), Article 155500
Guo-Lin Wang, Hui-Xia Gao, Xiang-Na Zhao
https://www.sciencedirect.com/science/article/pii/S1043466621000806/pdfft?md5=8010d7e49f8a7382a48d7b58aadb510a&pid=1-s2.0-S1043466621000806-main.pdf
39. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development
Pharmacological Research, 26 March 2021, Volume 168 (Cover date: June 2021), Article 105581
Vincenzo Lionetti, Sveva Bollini, Tommaso Angelone
https://www.sciencedirect.com/science/article/pii/S1043661821001651/pdfft?md5=eea5510458b722a6f8ce387cdbd2dcc1&pid=1-s2.0-S1043661821001651-main.pdf
40. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages
Heliyon, 2 February 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06187
Ken Shirato, Takako Kizaki
https://www.sciencedirect.com/science/article/pii/S2405844021002929/pdfft?md5=ca2404ef24aead65ef1253b2ee61dab8&pid=1-s2.0-S2405844021002929-main.pdf
41. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Cytokine & Growth Factor Reviews, 19 February 2021, Volume 58 (Cover date: April 2021), Pages 1-15
Narayanappa Amruta, Wesley H. Chastain, Gregory Bix
https://www.sciencedirect.com/science/article/pii/S1359610121000186/pdfft?md5=719828aa5074e854711f8a7c4683e6d6&pid=1-s2.0-S1359610121000186-main.pdf
42. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
Cytokine & Growth Factor Reviews, 9 February 2021, Volume 58 (Cover date: April 2021), Pages 55-65
Jorge Quarleri, M. Victoria Delpino
https://www.sciencedirect.com/science/article/pii/S1359610121000034/pdfft?md5=dc64ad81f0c3b61c7dd7760db20edce3&pid=1-s2.0-S1359610121000034-main.pdf
43. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019
Clinica Chimica Acta, 22 February 2021, Volume 517 (Cover date: June 2021), Pages 48-53
Ding-Hui Peng, Yi Luo, Wei Chen
https://www.sciencedirect.com/science/article/pii/S000989812100053X/pdfft?md5=3ef86870317ceb3ea74dbcc61dc7d490&pid=1-s2.0-S000989812100053X-main.pdf
44. Combined recombinase polymerase amplification/rkDNA–graphene oxide probing system for detection of SARS-CoV-2
Analytica Chimica Acta, 19 March 2021, Volume 1158 (Cover date: 8 May 2021), Article 338390
Moon Hyeok Choi, Jaehyeon Lee, Young Jun Seo
https://www.sciencedirect.com/science/article/pii/S0003267021002166/pdfft?md5=2e0135a89f63dc41066edc105f52e863&pid=1-s2.0-S0003267021002166-main.pdf
45. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
Journal of Molecular Structure, 26 March 2021, Volume 1237 (Cover date: 5 August 2021), Article 130366
Kalyan Ghosh, Sk. Abdul Amin, Tarun Jha
https://www.sciencedirect.com/science/article/pii/S0022286021004993/pdfft?md5=35fb4f4ae4fa368ef6066f5b58fcbed1&pid=1-s2.0-S0022286021004993-main.pdf
46. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
Journal of Allergy and Clinical Immunology, 9 February 2021, Volume 147, Issue 4 (Cover date: April 2021), Pages 1226-1233.e2
Christian Rosas-Salazar, Kyle S. Kimura, Suman R. Das
https://www.sciencedirect.com/science/article/pii/S0091674921001779/pdfft?md5=70bc598c94c0654c211a483068950be3&pid=1-s2.0-S0091674921001779-main.pdf
47. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19
Heliyon, 28 January 2021, Volume 7, Issue 2 (Cover date: February 2021), Article e06133
Fahd Al-Mulla, Anwar Mohammad, Thangavel Alphonse Thanaraj
https://www.sciencedirect.com/science/article/pii/S2405844021002383/pdfft?md5=0bbf48aaced52c9cd5e11c3768356129&pid=1-s2.0-S2405844021002383-main.pdf
48. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
Biochimica et Biophysica Acta (BBA) - General Subjects, 14 March 2021, Volume 1865, Issue 6 (Cover date: June 2021), Article 129893
Wen-Hsiang Chen, Junfei Wei, Maria Elena Bottazzi
https://www.sciencedirect.com/science/article/pii/S0304416521000519/pdfft?md5=b6a35cfb1cb9e4256a63305df5c4ba35&pid=1-s2.0-S0304416521000519-main.pdf
49. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
iScience, 9 March 2021, Volume 24, Issue 4 (Cover date: 23 April 2021), Article 102293
Xiaoyuan Lin, Beibei Fu, Haibo Wu
https://www.sciencedirect.com/science/article/pii/S2589004221002613/pdfft?md5=5f15b7895de6485df52a32adcf79cc3a&pid=1-s2.0-S2589004221002613-main.pdf
50. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection
Journal of Lipid Research, 2 March 2021, Volume 62 (Cover date: 2021), Article 100061
James R. Hilser, Yi Han, Hooman Allayee
https://www.sciencedirect.com/science/article/pii/S0022227521000432/pdfft?md5=7179335eb03cddebe2a8610319d65bce&pid=1-s2.0-S0022227521000432-main.pdf
51. Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis
International Journal of Infectious Diseases, 11 February 2021, Volume 105 (Cover date: April 2021), Pages 351-356
Januar Wibawa Martha, Raymond Pranata, Michael Anthonius Lim
https://www.sciencedirect.com/science/article/pii/S1201971221001156/pdfft?md5=21851bf1e33b4efc1f3bc71944e31f38&pid=1-s2.0-S1201971221001156-main.pdf
52. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
Chemico-Biological Interactions, 18 February 2021, Volume 338 (Cover date: 1 April 2021), Article 109420
Yajing Hou, Shuai Ge, Langchong He
https://www.sciencedirect.com/science/article/pii/S0009279721000569/pdfft?md5=a206d7ce9233164962a3671953b37b64&pid=1-s2.0-S0009279721000569-main.pdf
53. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.
EBioMedicine, 2 April 2021, Volume 66 (Cover date: April 2021), Article 103317
Aishwarya Venkataraman, Nathella Pavan Kumar, Subash Babu
https://www.sciencedirect.com/science/article/pii/S2352396421001109/pdfft?md5=9fed96ef86925307edcb6b6aacf2cc0f&pid=1-s2.0-S2352396421001109-main.pdf
54. The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review
Heart & Lung, 27 February 2021, Volume 50, Issue 4 (Cover date: July–August 2021),Pages 481-490
Woon H. Chong, Biplab K. Saha, Amit Chopra
https://www.sciencedirect.com/science/article/pii/S0147956321000522/pdfft?md5=2e5c0ab3789b04b35c9b64dfebb4d47d&pid=1-s2.0-S0147956321000522-main.pdf
55. Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
Multiple Sclerosis and Related Disorders, 13 March 2021, Volume 51 (Cover date: June 2021), Article 102900
Nurhan Kaya Tutar, Sami Omerhoca, Nilufer Kale
https://www.sciencedirect.com/science/article/pii/S221103482100167X/pdfft?md5=27347de64ff6e05021f59ccd3eb73781&pid=1-s2.0-S221103482100167X-main.pdf
56. Forensic evaluation of two nucleic acid extraction systems and validation of a RT-qPCR protocol for identification of SARS-CoV-2 in post-mortem nasopharyngeal swabs
Forensic Science International, 2 April 2021m Volume 323 (Cover date: June 2021)m Article 110775
Pedro A. Barrio, Amparo Fernández-Rodríguez, Antonio Alonso
https://www.sciencedirect.com/science/article/pii/S0379073821000955/pdfft?md5=e7ae8811c06b89ba3a42d25a948b1327&pid=1-s2.0-S0379073821000955-main.pdf
57. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
Virology, 5 March 2021, Volume 558 (Cover date: June 2021), Pages 13-21
Kaustuv Nayak, Kamalvishnu Gottimukkala, Anmol Chandele
https://www.sciencedirect.com/science/article/pii/S0042682221000362/pdfft?md5=ebbc1b9bd063eed02f11ab5485f107b4&pid=1-s2.0-S0042682221000362-main.pdf
58. A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19
Journal of Infection and Chemotherapy, 19 February 2021, Volume 27, Issue 6 (Cover date: June 2021), Pages 876-881
Wei-Jing Gong, Tao Zhou, Xue-Feng Cai
https://www.sciencedirect.com/science/article/pii/S1341321X21000581/pdfft?md5=4696eae29cdcb71818450ee15c3dbbb2&pid=1-s2.0-S1341321X21000581-main.pdf
59. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Cell, 2 February 2021, Volume 184, Issue 5 (Cover date: 4 March 2021), Pages 1201-1213.e14
Aurélien Sokal, Pascal Chappert, Matthieu Mahévas
https://www.sciencedirect.com/science/article/pii/S0092867421000933/pdfft?md5=7a78e7cc53c26036e43ae676756b65a7&pid=1-s2.0-S0092867421000933-main.pdf
60. Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
International Journal of Biological Macromolecules, 4 February 2021, Volume 176 (Cover date: 15 April 2021), Pages 1-12
Ashuai Du, Rong Zheng, Zanxian Xia
https://www.sciencedirect.com/science/article/pii/S0141813021002804/pdfft?md5=2e0f812693f83685cc35080667c3c5a5&pid=1-s2.0-S0141813021002804-main.pdf
61. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Cell Reports, 12 March 2021, Volume 34, Issue 13 (Cover date: 30 March 2021), Article 108915
Yang Li, Ming-liang Ma, Sheng-ce Tao
https://www.sciencedirect.com/science/article/pii/S2211124721002291/pdfft?md5=210219517fbb8ab65297968c10c66803&pid=1-s2.0-S2211124721002291-main.pdf
62. Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment
Biomedicine & Pharmacotherapy, 8 April 2021, Volume 139 (Cover date: July 2021), Article 111586
Jing Qian, Hangdi Xu, Xiaohui Fan
https://www.sciencedirect.com/science/article/pii/S0753332221003711/pdfft?md5=cf167e9de79f35358e27107573dbe72d&pid=1-s2.0-S0753332221003711-main.pdf
63. Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?
Medical Hypotheses, 25 March 2021, Volume 151 (Cover date: June 2021), Article 110570
Selma Rivas-Fuentes, Víctor Julián Valdés, Alfonso Salgado-Aguayo
https://www.sciencedirect.com/science/article/pii/S0306987721000888/pdfft?md5=101c312977ad9945a0ff03eba09808a9&pid=1-s2.0-S0306987721000888-main.pdf
64. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
International Journal of Biological Macromolecules, 16 April 2021, Volume 181 (Cover date: 30 June 2021), Pages 801-809
Sk. Sarif Hassan, Diksha Attrish, Adam M. Brufsky
https://www.sciencedirect.com/science/article/pii/S0141813021007509/pdfft?md5=d85b3e326da61739d7b396c3b4db19b7&pid=1-s2.0-S0141813021007509-main.pdf
65. Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues
International Immunopharmacology, 10 March 2021, Volume 95 (Cover date: June 2021), Article 107567
Bingfeng Zheng, Manman Yuan, Qiang Xu
https://www.sciencedirect.com/science/article/pii/S1567576921002034/pdfft?md5=ccd05137be88e0d281c4dd0a5cb8d45a&pid=1-s2.0-S1567576921002034-main.pdf
66. Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation
Heliyon, 5 March 2021, Volume 7, Issue 3 (Cover date: March 2021), Article e06435
Md. Kamrul Hasan, Mohammad Kamruzzaman, Atiqur Rahman
https://www.sciencedirect.com/science/article/pii/S2405844021005405/pdfft?md5=c463dfaa8c2baf857f8801a81cb7e779&pid=1-s2.0-S2405844021005405-main.pdf
67. Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy
International Journal of Infectious Diseases, 2 February 2021, Volume 104 (Cover date: March 2021), Pages 696-700
Moris Sangineto, Fabio Arena, Gaetano Serviddio
https://www.sciencedirect.com/science/article/pii/S1201971221000801/pdfft?md5=1561cc88be26a34eab69c9504369f043&pid=1-s2.0-S1201971221000801-main.pdf
68. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
Cell, 9 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1865-1883.e20
Lei Sun, Pan Li, Qiangfeng Cliff Zhang
https://www.sciencedirect.com/science/article/pii/S0092867421001586/pdfft?md5=cc2f429b87ba74188613c74ee476e625&pid=1-s2.0-S0092867421001586-main.pdf
69. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes
iScience, 12 February 2021, Volume 24, Issue 3 (Cover date: 19 March 2021), Article 102187
Ziliang Zhou, Chunliu Huang, Shoudeng Chen
https://www.sciencedirect.com/science/article/pii/S2589004221001553/pdfft?md5=9caa9f6681cb93988a7c92b61000ef5d&pid=1-s2.0-S2589004221001553-main.pdf
70. Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19
International Journal of Infectious Diseases, 27 February 2021, Volume 105 (Cover date: April 2021), Pages 463-469
Cyrine Bennasrallah, Imen Zemni, Asma Sriha Belguith
https://www.sciencedirect.com/science/article/pii/S1201971221001752/pdfft?md5=7e45ee450dedc3d30d068801238d3713&pid=1-s2.0-S1201971221001752-main.pdf
71. Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2
Journal of Virological Methods, 8 April 2021, Volume 293 (Cover date: July 2021), Article 114151
Kanti Pabbaraju, Anita A. Wong, Graham A. Tipples
https://www.sciencedirect.com/science/article/pii/S0166093421000902/pdfft?md5=5a478167e395cc7fe676cd7ebde54ff7&pid=1-s2.0-S0166093421000902-main.pdf
72. Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Biomedicine & Pharmacotherapy, 25 February 2021, Volume 138 (Cover date: June 2021), Article 111437
Justin Fortune Creeden, Ali Sajid Imami, Cheryl B. McCullumsmith
https://www.sciencedirect.com/science/article/pii/S0753332221002225/pdfft?md5=120b8630139be608e593468ff278c39f&pid=1-s2.0-S0753332221002225-main.pdf
73. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm
Nano Today, 8 April 2021, Volume 38 (Cover date: June 2021), Article 101149
Hyelim Kim, Han Sol Lee, Wonhwa Lee
https://www.sciencedirect.com/science/article/pii/S1748013221000748/pdfft?md5=40c9c6300b52b47ea1bc58e311a57f70&pid=1-s2.0-S1748013221000748-main.pdf
74. Relationship between blood eosinophil levels and COVID-19 mortality
World Allergy Organization Journal, 11 February 2021, Volume 14, Issue 3 (Cover date: March 2021), Article 100521
Bingdi Yan, Junling Yang, Xiaolei Tang
https://www.sciencedirect.com/science/article/pii/S1939455121000156/pdfft?md5=96505965a7f5b59c93f93d8aaf5e498f&pid=1-s2.0-S1939455121000156-main.pdf
75. Factors associated with viral clearance periods from patients with COVID-19: A retrospective observational cohort study
Journal of Infection and Chemotherapy, 18 February 2021, Volume 27, Issue 6 (Cover date: June 2021), Pages 864-868
Nobuyasu Hirai, Yuichi Nishioka, Kei Kasahara
https://www.sciencedirect.com/science/article/pii/S1341321X21000556/pdfft?md5=ba4d3f5b54ce35cba69d3f7e1dff7180&pid=1-s2.0-S1341321X21000556-main.pdf
76. Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus
Journal of Biological Chemistry, 25 February 2021, Volume 296 (Cover date: 2021), Article 100470
Einat B. Vitner, Hagit Achdout, Tomer Israely
https://www.sciencedirect.com/science/article/pii/S002192582100243X/pdfft?md5=49150c24163357c334c918c04763e37f&pid=1-s2.0-S002192582100243X-main.pdf
77. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Cell, 23 February 2021, Volume 184, Issue 7 (Cover date: 1 April 2021), Pages 1821-1835.e16
Emanuele Andreano, Emanuele Nicastri, Rino Rappuoli
https://www.sciencedirect.com/science/article/pii/S0092867421002245/pdfft?md5=e05e0f0b55f7132bce1ef6b6b9a4c984&pid=1-s2.0-S0092867421002245-main.pdf
78. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Virology, 22 February 2021, Volume 558 (Cover date: June 2021), Pages 1-12
Ahmed S. Abdel-Moneim, Elsayed M. Abdelwhab, Ziad A. Memish
https://www.sciencedirect.com/science/article/pii/S0042682221000416/pdfft?md5=d65baec3701c624ae61006765660a179&pid=1-s2.0-S0042682221000416-main.pdf
79. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
European Journal of Pharmacology, 3 February 2021, Volume 896 (Cover date: 5 April 2021), Article 173930
Mohammad A. I. Al-Hatamleh, Ma'mon M. Hatmal, Rohimah Mohamud
https://www.sciencedirect.com/science/article/pii/S0014299921000832/pdfft?md5=0f8ee2ef6e825829b4fdd591998d70c4&pid=1-s2.0-S0014299921000832-main.pdf
80. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
Med, 10 February 2021, Volume 2, Issue 3 (Cover date: 12 March 2021), Pages 281-295.e4
Natalia Sherina, Antonio Piralla, Qiang Pan-Hammarström
https://www.sciencedirect.com/science/article/pii/S2666634021000386/pdfft?md5=6fc656d976f81d86c20c6559ff0467fd&pid=1-s2.0-S2666634021000386-main.pdf
81. Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing
Journal of Hospital Infection, 8 February 2021, Volume 110 (Cover date: April 2021), Pages 178-183
S. Paltansing, R. S. Sikkema, P. de Man
https://www.sciencedirect.com/science/article/pii/S0195670121000517/pdfft?md5=3a1250f67e7b1a5cc9dea067f50d890a&pid=1-s2.0-S0195670121000517-main.pdf
82. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR
International Journal of Infectious Diseases, 5 February 2021, Volume 105 (Cover date: April 2021), Pages 7-14
Yosuke Hirotsu, Makoto Maejima, Masao Omata
https://www.sciencedirect.com/science/article/pii/S1201971221000904/pdfft?md5=efd7f87372109fce85986674c28f1b78&pid=1-s2.0-S1201971221000904-main.pdf
83. Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry
Journal of Colloid and Interface Science, 10 March 2021, Volume 594 (Cover date: 15 July 2021), Pages 195-203
Ieva Plikusiene, Vincentas Maciulis, Arunas Ramanavicius
https://www.sciencedirect.com/science/article/pii/S0021979721002526/pdfft?md5=a557eef68f90c85747544da963734bbe&pid=1-s2.0-S0021979721002526-main.pdf
WILEY
1. Factors associated with SARS‐CoV‐2 infection in patients attending an acute hospital ambulatory assessment unit
G Ronan, L Kumar M Davey, C O'Leary, S McAleer, J Lynch R Lavery, J Campion, J Ryan, PJ O'Donoghue A Daly, J Shanahan, S Costelloe, C Sadlier, C McGlade, S Manning, J Carroll, S O'Flynn, P Barry, J Chevarria
Journal of Medical Virology
First published: 26 March 2021
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26966
2. COVID‐19 with and without anosmia or dysgeusia: A case‐control study
Nishanth Dev, Jhuma Sankar, Nitesh Gupta, Ramesh Chand Meena, Charanjit Singh, D. K. Gupta, M. K. Sen
Journal of Medical Virology,Volume 93, Issue 4
First published: 08 January 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26784
3. Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients
Jie Cheng, Xiang Zhou, Weijun Feng, Min Jia, Xinlu Zhang, Taixue An, Minyuan Luan, Yi Pan, Shu Zhang, Zhaoming Zhou, Lei Wen, Yun Sun, Cheng Zhou
Journal of Cellular and Molecular Medicine
First published: 23 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.16444
4. Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data
Abbas Khan, Tauqir Zia, Muhammad Suleman, Taimoor Khan, Syed Shujait Ali, Aamir Ali Abbasi, Anwar Mohammad, Dong‐Qing Wei
Journal of Cellular Physiology
First published: 23 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcp.30367
5. Use of Chlorhexidine to Eradicate Oropharyngeal SARS‐CoV‐2 in COVID‐19 Patients
Y. Hanna Huang B.A., Jong T. Huang M.D.
Journal of Medical Virology
First published: 23 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26954
6. SARS‐CoV‐2‐specific serological and functional T‐cell Immune responses during acute and early COVID‐19 convalescence in Solid Organ Transplant patients
Alexandre Favà, Laura Donadeu, Nuria Sabé, Vincent Pernin, José Gonzalez ‐ Costello, Laura Lladó, Maria Meneghini, Elena Garcia ‐ Romero, Alba Cachero, Alba Torija, Ronny Rodriguez ‐ Urquia, Elena Crespo, Iris Teubel, Edoardo Melilli, Nuria Montero, Anna Manonelles, Rosemarie Preyer, Kevin Strecker, Anne Ovize, Juan J Lozano, Julia Sidorova, Josep M Cruzado, Moglie Le Quintrec, Olivier Thaunat, Oriol Bestard
American Journal of Transplantation
First published: 23 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajt.16570
7. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysis
Anupam Kumar Singh, Anuraag Jena, Praveen Kumar‐M, Vishal Sharma, Shaji Sebastian
United European Gastroenterology Journal
First published: 23 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1177/2050640620972602
8. Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
Antonio Recchiuti, Sara Patruno, Domenico Mattoscio, Elisa Isopi, Antonella Pomilio, Alessia Lamolinara, Manuela Iezzi, Romina Pecce, Mario Romano
The FASEB Journal
First published: 22 March 2021
https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.202001952R
9. Quantitative pleural line characterization outperforms traditional lung texture ultrasound features in detection of COVID‐19
Laith R. Sultan MD, MPH, Yale Tung Chen MD Theodore W. Cary MS, Khalid Ashi MD, Chandra M. Sehgal PhD
Journal of the American College of Emergency Physicians Open
First published: 02 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/emp2.12418
10. Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications
Tosti J. Mankelow, Belinda K. Singleton, Pedro L. Moura, Christian J. Stevens‐Hernandez, Nicola M. Cogan, Gyongyver Gyorffy, Sabine Kupzig, Luned Nichols, Claire Asby, Jennifer Pooley, Gabriella Ruffino, Faroakh Hosseini, Fiona Moghaddas, Marie Attwood, Alan Noel, Alex Cooper, David T. Arnold, Fergus Hamilton, Catherine Hyams, Adam Finn , Ashley M. Toye, David J. Anstee
eJHaem
First published: 02 April 2021
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.180
11. Relationship between viral load, infection‐to‐delivery interval and mother‐to‐child transfer of anti‐SARS‐CoV‐2 antibodies
L. C. Poon, B. W. Leung T. Ma, F. N. Yu C. W. Kong, T. K. Lo, P. L. So, W. C. Leung, W. Shu, K. W. Cheung, S. Moungmaithong, C. C. Wang
Ultrasound in Obstetrics & Gynecology
First published: 02 April 2021
https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/uog.23639
12. Detectable respiratory SARS‐CoV‐2 RNA is associated with low vitamin D levels and high social deprivation
Mark Livingston, Aiden Plant, Simon Dunmore, Andrew Hartland, Stephen Jones, Ian Laing, Sudarshan Ramachandran
International Journal of Clinical Practice
First published: 02 April 2021
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14166
13. Discovery of Potent Covid‐19 Main Protease Inhibitors using Integrated Drug Repurposing Strategy
T. Muthu Kumar, K. Rohini, Nivya James, V. Shanthi, K. Ramanathan
Biotechnology and Applied Biochemistry
First published: 01 April 2021
https://iubmb.onlinelibrary.wiley.com/doi/epdf/10.1002/bab.2159
14. Ultrasound and Doppler findings in pregnant SARS‐CoV‐2 positive women
E. Soto‐Torres, E. Hernandez Andrade, E. Huntley, H. Mendez‐Figueroa, S. C. Blackwell
Ultrasound in Obstetrics & Gynecology
First published: 01 April 2021
https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/uog.23642
15. The ROX index can be a useful tool for the triage evaluation of COVID‐19 patients with dyspnoea
Arian Zaboli, Dietmar Ausserhofer, Norbert Pfeifer, Serena Sibilio, Giovanna Tezza, Laura Ciccariello, Gianni Turcato
Journal of Advanced Nursing
First published: 01 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jan.14848
16. Effect of corticosteroids on mortality in hospitalized COVID‐19 patients not receiving invasive mechanical ventilation
Federica Fusina, Filippo Albani, Enza Granato, Angelo Meloni, Renzo Rozzini, Tony Sabatini, Roberto Stellini , Paolo Terragnoli, Antonio Rosano, Mohammed Abu Hilal, Giuseppe Natalini
Clinical Pharmacology & Therapeutics
First published: 31 March 2021
https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2245
17. Increased B Cell activity with consumption of activated monocytes in severe COVID‐19 patients
Igor Kos, Benedikt Balensiefer, Vadim Lesan, Dominic Kaddu‐Mulindwa, Lorenz Thurner, Konstantin Christofyllakis, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Martina Seiffert, Stefan Wagenpfeil, Yvonne Bewarder, Frank Neumann, Torben Rixecker, Sigrun Smola, Andreas Link, Marcin Krawczyk, Frank Lammert, Philipp M. Lepper, Robert Bals, Stephan Stilgenbauer, Moritz Bewarder
European Journal of Immunology
First published: 31 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049163
18. Field evaluation of COVID‐19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity and low cost
Elaine M Matsuda, Ivana Barros de Campos, Isabela Penteriche de Oliveira, Daniela Rodrigues Colpas Andreia Moreira dos Santos Carmo, Luís Fernando de Macedo Brígido
Journal of Medical Virology
First published: 31 March 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26985
19. Short‐term impact of nursing home SARS‐CoV‐2 vaccinations on new infections, hospitalizations, and deaths
Vincent Mor PhD, Roee Gutman PhD, Xiaofei Yang ScM, Elizabeth M. White APRN, PhD Kevin W. McConeghy PharmD, MS Richard A. Feifer MD, MPH Carolyn R. Blackman MD Cyrus M. Kosar MS Barbara H. Bardenheier PhD Stefan A. Gravenstein MD, MPH
Journal of the American Geriatrics Society
First published: 16 April 2021
https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.17176
20. Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS‐CoV‐2
Alaa Shaheen
BioEssays
First published: 15 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/bies.202000312
21. Impact of cancer history on outcomes among hospitalized COVID‐19 patients
Isaac A. Klein MD, PhD Shoshana M. Rosenberg ScD, MPH Kerry L. Reynolds MD Leyre Zubiri MD, PhD Rachel Rosovsky MD Andrew J. Piper‐Vallillo MD Xin Gao MD Genevieve Boland MD, PhD Aditya Bardia MBBS, MPH Rachel Gaither BS Hannah Freeman BA Gregory J. Kirkner MPH Chanu Rhee MD, MPH Michael Klompas MD Meghan A. Baker MD, ScD Martha Wadleigh MD Eric P. Winer MD Camille N. Kotton MD Ann H. Partridge MD, MPH
The Oncologist
First published: 15 April 2021
https://theoncologist.onlinelibrary.wiley.com/doi/epdf/10.1002/onco.13794
22. Diabetic ketoacidosis drives COVID‐19 related hospitalizations in children with type 1 diabetes
G. Todd Alonso, Osagie Ebekozien, Mary Pat Gallagher, Saketh Rompicherla, Sarah K. Lyons Abha Choudhary, Shideh Majidi, Catherina T. Pinnaro, Sadana Balachandar, Mariam Gangat, Alissa Jeanne Curda ,Roberts Brynn E. Marks, Ana Creo, Janine Sanchez, Tossaporn Seeherunvong, Jose Jimenez‐Vega, Neha S. Patel, Jamie R. Wood Liana Gabriel, Kathryn M. Sumpte,r Meredith Wilkes, Robert Rapaport, Anna Cymbaluk ,Jenise C. Wong, Srinath Sanda, Anastasia Albanese‐O'neill
Journal of Diabetes
First published: 14 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/1753-0407.13184
23. Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit
Chiara Novelli, Erika Borotto, Ivo Beverina, Veronica Punzi, Danilo Radrizzani, Bruno Brando
International Journal of Laboratory Hematology
First published: 14 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.13543
24. Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics
Enrico Capuzzi, Alice Caldiroli, Silvia Leo, Massimiliano Buoli, Massimo Clerici
Human Psychopharmacology: Clinical and Experimental
First published: 14 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/hup.2789
25. Comparison of saliva with oral and nasopharyngeal swabs for SARS‐CoV‐2 detection on various commercial and laboratory developed assays
Annie‐Claude Labbé MD, Patrick Benoit MD, Sarah Gobeille Paré MD, François Coutlée MD, Simon Lévesque PhD, Mcb.A., RMCCM Julie Bestman‐Smith MD, PhD, Jeannot Dumaresq MD, Christian Lavallée MD, Claudia Houle MD, Philippe Martin MD, Anton Mak MD, Philippe Gervais MD, Stéphanie Langevin MD, Mariève Jacob‐Wagner MSc, Simon Gagnon PhD, Manon St‐Hilaire MT, Nathalie Lussier MD, Ariane Yechouron MD, David Roy PhD ,Michel Roger MD, PhD Judith Fafard MD
Journal of Medical Virology
First published: 14 April 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27026
26. Novel 1,2,3‐Triazole Derivatives as Potential Inhibitors against Covid‐19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies
Mohamed Reda Aouad, Daoud J. O. Khan, Musa A. Said, Nadia S. Al‐Kaff, Nadjet Rezki, Adeeb A. Ali ,Nahla Bouqellah, Mohamed Hagar
ChemistrySelect
First published: 14 April 2021
https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/slct.202100522
SPRINGER NATURE
1. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Meng-Hsuan Lin, Yi-Ping Huang, Chi-Fon Chang, Chun-Hua Hsu in Biomolecular NMR Assignments (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12104-020-09996-x.pdf
2. Backbone chemical shift spectral assignments of SARS coronavirus-2 non-structural protein nsp9
Erika F. Dudás, Rita Puglisi, Sophie Marianne Korn… in Biomolecular NMR Assignments (2021)
https://link.springer.com/content/pdf/10.1007/s12104-021-10011-0.pdf
3. Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
Dacre Knight, Katheryne Downes, Bala Munipalli… in SN Comprehensive Clinical Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs42399-021-00746-1.pdf
4. Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study
Pablo Sieber, Domenica Flury, Sabine Güsewell, Werner C. Albrich… in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-05957-4.pdf
5. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19)
Rosemond Qian-Xiu Tan, Wai Tak Victor Li, Wing-Zi Shum… in Systematic Reviews (2021)
https://link.springer.com/content/pdf/10.1186/s13643-021-01624-6.pdf
6. Clinical Application of Chest Computed Tomography (CT) in Detection and Characterization of Coronavirus (Covid-19) Pneumonia in Adults
Mohamed N. E. Kassem, Doaa T. Masallat in Journal of Digital Imaging (2021)
https://link.springer.com/content/pdf/10.1007/s10278-021-00426-5.pdf
7. Upper Extremity Arterial Thromboembolism in a Coronavirus Patient. A Case Report
Beverley-Ann Scott, Karan Garg, William Johnson… in SN Comprehensive Clinical Medicine (2021)
https://link.springer.com/content/pdf/10.1007/s42399-020-00694-2.pdf
8. Temporal relationship between serial RT-PCR results and serial chest CT imaging, and serial CT changes in coronavirus 2019 (COVID-19) pneumonia: a descriptive study of 155 cases in China
Jinfeng Gu, Li Yang, Tao Li, Ye Liu, Jing Zhang, Kejia Ning… in European Radiology (2021)
https://link.springer.com/content/pdf/10.1007/s00330-020-07268-9.pdf
9. The risk of transmission of the novel coronavirus (SARS-CoV-2) with human heart valve transplantation: evaluation of cardio-vascular tissues from two consecutive heart donors with asymptomatic COVID-19
R. Jashari, M. Van Esbroeck, J. Vanhaebost, I. Micalessi… in Cell and Tissue Banking (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10561-021-09913-z.pdf
10. Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations
Zhanna Belaya, Olga Golounina, Galina Melnichenko, Natalia Tarbaeva… in Endocrine (2021)
https://link.springer.com/content/pdf/10.1007/s12020-021-02674-5.pdf
11. Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)
Shobha Upreti, Jyoti Sankar Prusty, Satish Chandra Pandey… in Molecular Diversity (2021)
https://link.springer.com/content/pdf/10.1007/s11030-020-10159-2.pdf
12. Pseudoviruses for the assessment of coronavirus disinfection by ozone
Ines Zucker, Yaal Lester, Joel Alter, Michal Werbner… in Environmental Chemistry Letters (2021)
https://link.springer.com/content/pdf/10.1007/s10311-020-01160-0.pdf
13. Experimental tracking and numerical mapping of novel coronavirus micro-droplet deposition through nasal inhalation in the human respiratory system
Hamidreza Mortazavy Beni, Hamed mortazavi… in Biomechanics and Modeling in Mechanobiology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10237-021-01434-8.pdf
14. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Yassir A. Almofti, Khoubieb Ali Abd-elrahman, Elsideeq E. M. Eltilib in BMC Immunology (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12865-021-00412-0.pdf
15. Early Warning Factors of Death in COVID-19 Patients
Min Shang, Jie Wei, Han-dong Zou, Qing-shan Zhou, Yun-ting Zhang… in Current Medical Science (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11596-021-2320-7.pdf
16. Peptides-based vaccine against SARS-nCoV-2 antigenic fragmented synthetic epitopes recognized by T cell and β-cell initiation of specific antibodies to fight the infection
Zainularifeen Abduljaleel, Faisal A. Al-Allaf, Syed A. Aziz in Bio-Design and Manufacturing (2021)
https://link.springer.com/content/pdf/10.1007%2Fs42242-020-00114-3.pdf
17. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein
Tianyi Gao, Yingdong Gao, Xiangxiang Liu, Zhenlin Nie, Huilin Sun… in BMC Microbiology (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12866-021-02107-3.pdf
18. Differences in Immune Responses between Children and Adults with COVID-19
Yin Yuan, Qiu-peng Wang, Dan Sun, Zu-bo Wu, Hua Peng… in Current Medical Science (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11596-021-2318-1.pdf
19. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples
Daniëlle A. T. Hanssen, Michiel Slaats… in European Journal of Clinical Microbiology … (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10096-021-04220-7.pdf
20. SARS-CoV-2 infection and thrombotic complications: a narrative review
Iraklis C. Moschonas, Alexandros D. Tselepis in Journal of Thrombosis and Thrombolysis (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11239-020-02374-3.pdf
21. Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients
Saibin Wang, Yijun Sheng, Junwei Tu, Lanlan Zhang in BMC Pulmonary Medicine (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12890-021-01422-9.pdf
22. Clinical characteristics and risk factors for mortality in cancer patients with COVID-19
Junnan Liang, Guannan Jin, Tongtong Liu, Jingyuan Wen, Ganxun Li… in Frontiers of Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11684-021-0845-6.pdf
23. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
Francis K. Yoshimoto in The Protein Journal (2021)
https://link.springer.com/content/pdf/10.1007/s10930-021-09967-8.pdf
24. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids
Ke-Ying Fang, Wen-Chao Cao, Tian-Ao Xie, Jie Lv, Jia-Xin Chen… in Human Genomics (2021)
https://link.springer.com/content/pdf/10.1186%2Fs40246-021-00316-5.pdf
25. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
Shima Moradi-kalbolandi, Keyvan Majidzadeh-A… in Probiotics and Antimicrobial Proteins (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12602-021-09773-9.pdf
26. Effects of SARS-CoV-2 infection on neuroimaging and neurobehavior in neonates
Kai Yan, Fei-Fan Xiao, Yu-Wei Jiang, Tian-Tian Xiao… in World Journal of Pediatrics (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12519-021-00423-2.pdf
27. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study
Zhi Ao, Yan Li, Jiawei Wei, Jinyue Jiang… in Clinical and Experimental Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10238-021-00687-y.pdf
28. Diagnosis of COVID-19 using CT scan images and deep learning techniques
Vruddhi Shah, Rinkal Keniya, Akanksha Shridharani, Manav Punjabi… in Emergency Radiology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10140-020-01886-y.pdf
29. Detection of SARS-CoV-2 in fecal samples with different pretreatment methods and PCR kits
Ranran Cao, Lirong Bao, Ming Pan, Cheng Zhang, Hongyu Liao, Li Liu… in BMC Microbiology (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12866-021-02118-0.pdf
30. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19
Xiaowei Xie, Xuelian Cheng, Gaoxiang Wang, Biao Zhang… in Science China Life Sciences (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11427-020-1880-y.pdf
31. Angiotensin-Converting Enzyme Type 2 as a Molecular Mediator for Infection of Cells with SARS-CoV and SARS-CoV-2 Viruses
A. O. Shpakov in Neuroscience and Behavioral Physiology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11055-021-01082-6.pdf
32. Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari… in Stem Cell Reviews and Reports (2021)
https://link.springer.com/content/pdf/10.1007%2Fs12015-020-10110-w.pdf
33. Methylene blue photochemical treatment as a reliable SARS-CoV-2 plasma virus inactivation method for blood safety and convalescent plasma therapy for COVID-19
Changzhong Jin, Bin Yu, Jie Zhang, Hao Wu, Xipeng Zhou… in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-05993-0.pdf
34. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group
Désirée Larenas-Linnemann, Jorge Luna-Pech… in Current Allergy and Asthma Reports (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11882-020-00986-6.pdf
35. Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors
Ahmad Sattari, Ali Ramazani… in Journal of the Iranian Chemical Society (2021)
https://link.springer.com/content/pdf/10.1007%2Fs13738-021-02235-7.pdf
36. Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
Anish Nag, Ritesh Banerjee, Rajshree Roy Chowdhury… in VirusDisease (2021)
https://link.springer.com/content/pdf/10.1007%2Fs13337-021-00654-x.pdf
37. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
Dongsheng Wang, Binqing Fu, Zhen Peng, Dongliang Yang… in Frontiers of Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11684-020-0824-3.pdf
38. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Jing Zhang, Xin Rao, Yiming Li, Yuan Zhu, Fang Liu… in Annals of Intensive Care (2021)
https://link.springer.com/content/pdf/10.1186%2Fs13613-020-00792-3.pdf
39. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes
Yuki Iwasaki, Takashi Abe, Toshimichi Ikemura in BMC Microbiology (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12866-021-02158-6.pdf
40. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
Sk. Abdul Amin, Kalyan Ghosh, Samayaditya Singh, Insaf Ahmed Qureshi… in Molecular Diversity (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11030-021-10198-3.pdf
41. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study
Arturo Artero MD PhD, Manuel Madrazo MD PhD… in Journal of General Internal Medicine (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11606-021-06626-7.pdf
42. Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics
Mohammad Uzzal Hossain… in Journal of Genetic Engineering and Biotech… (2021)
https://link.springer.com/content/pdf/10.1186%2Fs43141-021-00152-z.pdf
43. The severity and atypical presentations of COVID-19 infection in pediatrics
Nagwan Y. Saleh, Hesham M. Aboelghar, Sherif S. Salem, Reda A. Ibrahem… in BMC Pediatrics (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12887-021-02614-2.pdf
44. Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors
Ramachandran Vijayan, Samudrala Gourinath in Journal of Proteins and Proteomics (2021)
https://link.springer.com/content/pdf/10.1007%2Fs42485-021-00059-w.pdf
45. A Novel Prediction Model for Long-Term SARS-CoV-2 RNA Shedding in Non-Severe Adult Hospitalized Patients with COVID-19: A Retrospective Cohort Study
Chen Lu Huang, Ling Fei, WeiXia Li, Wei Xu, Xu Dong Xie… in Infectious Diseases and Therapy (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40121-021-00437-3.pdf
46. Embedded System Prototype to Fight Covid-19 Pandemic Contamination with Less Cost
H. E. Adardour, M. Hadjila, S. M. H. Irid… in Wireless Personal Communications (2021)
https://link.springer.com/content/pdf/10.1007%2Fs11277-021-08429-9.pdf
47. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh… in BMC Infectious Diseases (2021)
https://link.springer.com/content/pdf/10.1186%2Fs12879-021-06045-3.pdf
48. Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
Jennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish… in Journal of Clinical Immunology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10875-021-00997-6.pdf
49. Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
Léna Petit, Léa Vernès, Jean-Paul Cadoret in Journal of Applied Phycology (2021)
https://link.springer.com/content/pdf/10.1007%2Fs10811-021-02372-9.pdf
50. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry
José David Torres-Peña, Luis M. Pérez-Belmonte, Francisco Fuentes-Jiménez… in Drugs (2021)
https://link.springer.com/content/pdf/10.1007%2Fs40265-021-01498-x.pdf
PUBMED:
1. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
Hoffmann HH, Sánchez-Rivera FJ, Schneider WM, Luna JM, Soto-Feliciano YM, Ashbrook AW, Le Pen J, Leal AA, Ricardo-Lax I, Michailidis E, Hao Y, Stenzel AF, Peace A, Zuber J, Allis CD, Lowe SW, MacDonald MR, Poirier JT, Rice CM.
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833927/pdf/main.pdf
2. Application of plasmapheresis for Covid-19 patients
Turgutkaya A, Yavaşoğlu İ, Bolaman Z.
Ther Apher Dial. 2021 Apr;25(2):248-249.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300871/pdf/TAP-9999-na.pdf
3. Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?
Rawat P, Jemimah S, Ponnuswamy PK, Gromiha MM.
Proteins. 2021 Apr;89(4):389-398.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753379/pdf/PROT-9999-na.pdf
4. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis
Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A.
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104299.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674980/pdf/main.pdf
5. Immunological characteristics govern the transition of COVID-19 to endemicity.
Lavine JS, Bjornstad ON, Antia R.
Science. 2021 Feb 12;371(6530):741-745.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932103/pdf/371_741.pdf
6. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system
Zhu Q, Zhang Y, Wang L, Yao X, Wu D, Cheng J, Pan X, Liu H, Yan Z, Gao L.
Antiviral Res. 2021 Mar;187:105015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801822/pdf/main.pdf
7. The SARS-CoV-2 RNA-protein interactome in infected human cells.
Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, Melanson R, Werner S, Wei Y, Zimmer M, Ade J, Kirschner L, Zielinski S, Dölken L, Lander ES, Caliskan N, Fischer U, Vogel J, Carr SA, Bodem J, Munschauer M.
Nat Microbiol. 2021 Mar;6(3):339-353.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906908/pdf/41564_2020_Article_846.pdf
8. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.
Ji D, Juhas M, Tsang CM, Kwok CK, Li Y, Zhang Y.
Brief Bioinform. 2021 Mar 22;22(2):1150-1160.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314185/pdf/bbaa114.pdf
9. SARS-Cov-2 ORF3a: Mutability and function.
Bianchi M, Borsetti A, Ciccozzi M, Pascarella S.
Int J Biol Macromol. 2021 Feb 15;170:820-826.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836370/pdf/main.pdf
10. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.
Miao G, Zhao H, Li Y, Ji M, Chen Y, Shi Y, Bi Y, Wang P, Zhang H.
Dev Cell. 2021 Feb 22;56(4):427-442.e5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832235/pdf/main.pdf
11. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Garvey LH, Nasser S.
Br J Anaesth. 2021 Mar;126(3):e106-e108
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834677/pdf/main.pdf